# John C. Morris

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-c-morris/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,980 |
| Field | Immunotherapy and Immune Responses |
| h-index | 39 |
| i10-index | 74 |
| Last Known Institution | Alzheimer's Association |
| OpenAlex ID | https://openalex.org/A5119576290 |
| ORCID iD | 0000-0002-2692-4565 |
| Works | 175 |

## Researcher papers

- [Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study](https://scholariq.org/papers/pembrolizumab-versus-methotrexate-docetaxel-or-cetuximab-for-recurrent-or/)
- [Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer](https://scholariq.org/papers/redistribution-hyperproliferation-activation-of-natural-killer-cells-and-cd8-t/)
- [Interleukin-15 biology and its therapeutic implications in cancer](https://scholariq.org/papers/interleukin-15-biology-and-its-therapeutic-implications-in-cancer/)
- [Transforming growth factor-β: A therapeutic target for cancer](https://scholariq.org/papers/transforming-growth-factor-a-therapeutic-target-for-cancer/)
- [Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model](https://scholariq.org/papers/simultaneous-blockade-of-multiple-immune-system-inhibitory-checkpoints-enhances/)
- [Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin](https://scholariq.org/papers/impacting-tumor-cell-fate-by-targeting-the-inhibitor-of-apoptosis-protein/)
- [TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis](https://scholariq.org/papers/tgf-signaling-in-myeloid-cells-is-required-for-tumor-metastasis/)
- [A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy](https://scholariq.org/papers/a-pilot-study-of-ctla-4-blockade-after-cancer-vaccine-failure-in-patients-with/)
- [Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)](https://scholariq.org/papers/cutaneous-keratoacanthomas-squamous-cell-carcinomas-associated-with/)
- [Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells](https://scholariq.org/papers/reduction-of-mhc-i-expression-limits-t-lymphocyte-mediated-killing-of-cancer/)
- [Lung Cancer-Initiating Cells Avoid Immune Recognition](https://scholariq.org/papers/lung-cancer-initiating-cells-avoid-immune-recognition/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [Alzheimer's Association](https://scholariq.org/institutions/alzheimer-s-association/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.